NCT06519019

Brief Summary

Dental implants have become more common treatment for replacing missing teeth and aim to improve chewing efficiency, physical health and esthetic. Researchers always tried to improve design, mechanical and chemical properties of implant. Major benefit of surface modification are to improve hydrophilicity, cell to implant adhesion and cell proliferation. These modification improve osseointegration and reduce treatment duration. In this study investigators are evaluating healing capacity of hydrophilic implant compared to conventional implant.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 25, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 25, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

July 12, 2024

Last Update Submit

July 19, 2024

Conditions

Keywords

Dental Implants

Outcome Measures

Primary Outcomes (3)

  • Implant Stability Using Resonance Frequency Analysis

    Implant stability is measured

    "Baseline", "2 weeks", "1 month", "3 months"

  • Marginal Bone Loss Using RVG and Grid.

    Marginal Bone Loss Measured

    "3 months"

  • Soft tissue healing

    Soft tissue healing will be assessed using Landry Turnbull and Howley Healing Index. Where soft tissue healing will be scored from 1 to 5, where score "1" indicate worse score and score "5" indicate Best score

    "1 Week", "2 weeks", "1 month", "3 months"

Study Arms (2)

Hydrophilic Dental Implant Group

EXPERIMENTAL

One dental implant placed will have hydrophilic properties.

Procedure: Dental Implant Surgery - Hydrophilic group

Conventional Dental Implant Group

ACTIVE COMPARATOR

This Conventional Dental implant group will act as control.

Procedure: Dental Implant Surgery - Conventional group

Interventions

A full thickness mucoperiosteal flap was elevated, under Local anaesthesia, osteotomy sites were prepared according to manufactures instructions, and parallel pin was used to confirm position and angulation of osteotomy site. One site received a hydrophilic implant and the other site received a conventional implant. Ostell ISQ was used to measure primary stability of the dental implant. The surgical wound closure was with mattress and single interrupted sutures, using 4-0 vicryl suture.

Hydrophilic Dental Implant Group

A full thickness mucoperiosteal flap was elevated, under Local anaesthesia, osteotomy sites were prepared according to manufactures instructions, and parallel pin was used to confirm position and angulation of osteotomy site. One site received a hydrophilic implant and the other site received a conventional implant. Ostell ISQ was used to measure primary stability of the dental implant. The surgical wound closure was with mattress and single interrupted sutures, using 4-0 vicryl suture.

Conventional Dental Implant Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least above 18 years of age.
  • Patients who needs replacement of two or more teeth in mandible.
  • Adequate bone volume to accommodate planned dental implants.

You may not qualify if:

  • General contraindication to dental implant treatment. (Uncontrolled diabetes and severe cardiovascular or infectious diseases).
  • Intravenous and oral bisphosphonate therapy.
  • Presence of severe, moderate or mild untreated periodontal disease.
  • Unwillingness to return for the follow-up examination.
  • Smokers.
  • Patients who are psychologically unable to participate.
  • Poor oral hygiene.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Prabhuji MLV, MDS

CONTACT

Swaroop Varghese M, BDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2024

First Posted

July 25, 2024

Study Start

July 1, 2024

Primary Completion

July 1, 2025

Study Completion

August 1, 2025

Last Updated

July 25, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Individual Participant Data will not be shared with other researchers.